2022 Q4 Form 20-F Financial Statement
#000117891323001230 Filed on March 30, 2023
Income Statement
Concept | 2022 Q4 | 2022 | 2021 Q4 |
---|---|---|---|
Revenue | $83.13M | $337.4M | $79.76M |
YoY Change | 4.23% | 13.34% | 42.7% |
Cost Of Revenue | $15.81M | $65.95M | $15.21M |
YoY Change | 3.95% | 27.5% | 56.84% |
Gross Profit | $67.32M | $271.4M | $64.54M |
YoY Change | 4.3% | 10.36% | 39.76% |
Gross Profit Margin | 80.98% | 80.45% | 80.93% |
Selling, General & Admin | $48.21M | $225.8M | $55.87M |
YoY Change | -13.7% | 8.18% | 53.52% |
% of Gross Profit | 71.62% | 83.18% | 86.56% |
Research & Development | $21.33M | $92.56M | $21.83M |
YoY Change | -2.3% | 16.73% | 60.86% |
% of Gross Profit | 31.68% | 34.1% | 33.82% |
Depreciation & Amortization | $1.995M | $10.19M | $2.772M |
YoY Change | -28.03% | 48.12% | 125.37% |
% of Gross Profit | 2.96% | 3.75% | 4.29% |
Operating Expenses | $69.54M | $346.0M | $77.69M |
YoY Change | -10.5% | 20.13% | 55.51% |
Operating Profit | -$2.222M | -$74.53M | -$13.15M |
YoY Change | -83.11% | 77.29% | 247.94% |
Interest Expense | $1.391M | $4.220M | -$5.636M |
YoY Change | -124.68% | -121.78% | 34.51% |
% of Operating Profit | |||
Other Income/Expense, Net | -$596.0K | ||
YoY Change | 344.78% | ||
Pretax Income | -$831.0K | -$70.91M | -$19.51M |
YoY Change | -95.74% | 9.34% | 144.82% |
Income Tax | $468.0K | $577.0K | $8.000K |
% Of Pretax Income | |||
Net Earnings | -$1.299M | -$71.49M | -$19.52M |
YoY Change | -93.35% | 9.96% | 141.58% |
Net Earnings / Revenue | -1.56% | -21.19% | -24.47% |
Basic Earnings Per Share | -$1.94 | ||
Diluted Earnings Per Share | -$0.04 | -$1.94 | -$543.1K |
COMMON SHARES | |||
Basic Shares Outstanding | 37.54M shares | 36.86M shares | |
Diluted Shares Outstanding | 36.86M shares |
Balance Sheet
Concept | 2022 Q4 | 2022 | 2021 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $462.0M | $462.0M | $323.3M |
YoY Change | 42.91% | 42.91% | -33.67% |
Cash & Equivalents | $86.75M | $86.75M | $71.15M |
Short-Term Investments | $241.3M | $241.3M | $118.2M |
Other Short-Term Assets | $144.2M | $144.2M | $130.7M |
YoY Change | 10.32% | 10.32% | 32.93% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | $19.02M | $14.29M | |
Total Short-Term Assets | $625.2M | $625.2M | $468.2M |
YoY Change | 33.53% | 33.53% | -20.8% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $5.660M | $14.74M | $18.28M |
YoY Change | -69.04% | -19.39% | -16.52% |
Goodwill | $77.27M | $77.27M | |
YoY Change | 0.0% | ||
Intangibles | $14.77M | $49.22M | |
YoY Change | -69.99% | ||
Long-Term Investments | $189.8M | $189.8M | $317.5M |
YoY Change | -40.21% | -40.21% | 39.26% |
Other Assets | $1.965M | $1.965M | $1.055M |
YoY Change | 86.26% | 86.26% | -64.83% |
Total Long-Term Assets | $298.6M | $298.6M | $463.4M |
YoY Change | -35.56% | -35.56% | 71.61% |
TOTAL ASSETS | |||
Total Short-Term Assets | $625.2M | $625.2M | $468.2M |
Total Long-Term Assets | $298.6M | $298.6M | $463.4M |
Total Assets | $923.8M | $923.8M | $931.6M |
YoY Change | -0.83% | -0.83% | 8.17% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $8.630M | $8.630M | $8.699M |
YoY Change | -0.79% | -0.79% | 141.64% |
Accrued Expenses | $2.755M | $42.64M | $3.055M |
YoY Change | -9.82% | -9.85% | -7.42% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $0.00 | $0.00 | $2.269M |
YoY Change | -100.0% | -100.0% | 278.17% |
Total Short-Term Liabilities | $197.1M | $197.1M | $189.0M |
YoY Change | 4.26% | 4.26% | 29.57% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $454.3M | $452.8M | $385.2M |
YoY Change | 17.95% | 21.69% | 8.16% |
Other Long-Term Liabilities | $1.559M | $8.208M | $10.48M |
YoY Change | -85.13% | -65.19% | -24.58% |
Total Long-Term Liabilities | $461.0M | $461.0M | $395.7M |
YoY Change | 16.51% | 16.51% | 6.93% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $197.1M | $197.1M | $189.0M |
Total Long-Term Liabilities | $461.0M | $461.0M | $395.7M |
Total Liabilities | $658.1M | $658.1M | $584.7M |
YoY Change | 12.55% | 12.55% | 13.36% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$288.0M | -$237.6M | |
YoY Change | 21.24% | ||
Common Stock | $0.00 | $0.00 | |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $265.7M | $265.7M | $346.9M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $923.8M | $923.8M | $931.6M |
YoY Change | -0.83% | -0.83% | 8.17% |
Cashflow Statement
Concept | 2022 Q4 | 2022 | 2021 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.299M | -$71.49M | -$19.52M |
YoY Change | -93.35% | 9.96% | 141.58% |
Depreciation, Depletion And Amortization | $1.995M | $10.19M | $2.772M |
YoY Change | -28.03% | 48.12% | 125.37% |
Cash From Operating Activities | $9.605M | $30.11M | $8.245M |
YoY Change | 16.49% | -20.83% | 72.49% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $68.00K | $1.198M | -$652.0K |
YoY Change | -110.43% | -146.47% | -41.26% |
Acquisitions | $0.00 | ||
YoY Change | -100.0% | ||
Other Investing Activities | -$76.45M | -$12.25M | -$81.99M |
YoY Change | -6.75% | -94.6% | -68.32% |
Cash From Investing Activities | -$76.52M | -$14.62M | -$82.64M |
YoY Change | -7.41% | -93.63% | -68.21% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $1.028M | ||
YoY Change | -61.21% | ||
Debt Paid & Issued, Net | $2.269M | ||
YoY Change | 301.59% | ||
Cash From Financing Activities | 1.715M | -$1.637M | 2.634M |
YoY Change | -34.89% | -31.71% | -99.37% |
NET CHANGE | |||
Cash From Operating Activities | 9.605M | $30.11M | 8.245M |
Cash From Investing Activities | -76.52M | -$14.62M | -82.64M |
Cash From Financing Activities | 1.715M | -$1.637M | 2.634M |
Net Change In Cash | -65.20M | $13.82M | -71.76M |
YoY Change | -9.14% | -107.13% | -144.6% |
FREE CASH FLOW | |||
Cash From Operating Activities | $9.605M | $30.11M | $8.245M |
Capital Expenditures | $68.00K | $1.198M | -$652.0K |
Free Cash Flow | $9.537M | $28.91M | $8.897M |
YoY Change | 7.19% | -28.81% | 51.05% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
2269000 | usd |
CY2022Q4 | fvrr |
Long Term Loan And Long Term Liabilities
LongTermLoanAndLongTermLiabilities
|
1559000 | usd |
CY2021Q4 | fvrr |
Long Term Loan And Long Term Liabilities
LongTermLoanAndLongTermLiabilities
|
13099000 | usd |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
37537563 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
37537563 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
36761108 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
36761108 | shares |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
0 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
0 | usd |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.94 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.81 | |
CY2020 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.46 | |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
36856140 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
36856140 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
35955014 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
35955014 | shares |
CY2020 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
32323636 | shares |
CY2020 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
32323636 | shares |
CY2020 | fvrr |
Issuance Costs
IssuanceCosts
|
1109000 | usd |
CY2020 | fvrr |
Stock Issued During Period Value New Issues1
StockIssuedDuringPeriodValueNewIssues1
|
129853000 | usd |
CY2020 | fvrr |
Convertible Notes Issuance Costs
ConvertibleNotesIssuanceCosts
|
2842000 | usd |
CY2020 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
|
99190000 | usd |
CY2020 | fvrr |
Stock Issued During Period Value Purchase Of Capped Call
StockIssuedDuringPeriodValuePurchaseOfCappedCall
|
-43240000 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
313000 | usd |
CY2022 | fvrr |
Stock Issued During Period Value Cumulative Effect Of Adopting Asu
StockIssuedDuringPeriodValueCumulativeEffectOfAdoptingAsu
|
-78157000 | usd |
CY2022 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
26000 | usd |
CY2021 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
13000 | usd |
CY2020 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-0 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
0 | usd |
CY2021 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
0 | usd |
CY2020 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
129853000 | usd |
CY2022 | us-gaap |
Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
|
0 | usd |
CY2021 | us-gaap |
Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
|
0 | usd |
CY2020 | us-gaap |
Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
|
43240000 | usd |
CY2022 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><strong>Note 1: - General</strong></span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Fiverr International Ltd. was incorporated on April 29, 2010, under the laws of Israel, and commenced operations on the same date.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Fiverr International Ltd. and its subsidiaries (the “Company”) operates a worldwide online marketplace for sellers to sell their services and buyers to buy them. The Company’s platform includes various categories across ten verticals, including Graphics & Design, Digital Marketing, Writing & Translation, Video & Animation, Music & Audio, Programming & Tech, Business, Data, Lifestyle and photography. </span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Company’s platform also includes a variety of value-added products including subscription-based content marketing platform, back-office platform, learning and development offerings, creative talent platform and freelancer management platform.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Commencing June 13, 2019, the ordinary shares of the Company are traded on the New York Stock Exchange.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"> </div> </div> | |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;text-indent:18pt;margin-bottom:0pt">a.<span style="padding-left:11.06pt">Use of estimates:</span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;text-indent:18pt;margin-bottom:0pt"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px">The preparation of consolidated financial statements, in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes.</div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px">The accounting estimates that require management’s subjective judgments include but are not limited to revenue recognition, income taxes, share-based compensation, purchase price allocation on acquisitions including determination of identifiable intangible assets of useful lives convertible notes borrowing rate, contingent consideration and impairment of intangible assets. The Company evaluates its estimates and judgments on an ongoing basis and revises them when necessary. Actual results may differ from the original or revised estimates.</div> </div> | |
CY2022 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ad.<span style="padding-left:6.06pt">Certain comparative figures have been reclassified to conform to the current year presentation.</span></span></span> | |
CY2021Q4 | fvrr |
Contingent Consideration Liability Fair Value Disclosure
ContingentConsiderationLiabilityFairValueDisclosure
|
13858000 | usd |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;text-indent:18pt;margin-bottom:0px">n.<span style="padding-left:10.5pt">Concentrations of credit risks:</span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;text-indent:18pt;margin-bottom:0px"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px"> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, bank deposits, investment in marketable securities, restricted deposit and derivatives, which are placed in major banks in Israel, Germany and the U.S.</p> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px">User funds are held by a payment service provider which, pursuant to the agreement, was engaged to hold the user funds on behalf of buyers and sellers in an account segregated from the payment service provider’s operating bank account.</div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;text-indent:36pt;margin-bottom:0px">The Company does not have off-balance sheet concentration of credit risks.</div> </div> | |
CY2022 | fvrr |
Business Combination Contingent Consideration Liability Arise During Year
BusinessCombinationContingentConsiderationLiabilityAriseDuringYear
|
1609000 | usd |
CY2022 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
|
12249000 | usd |
CY2022Q4 | fvrr |
Contingent Consideration Liability Fair Value Disclosure
ContingentConsiderationLiabilityFairValueDisclosure
|
0 | usd |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6386203 | shares |
CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5840619 | shares |
CY2020 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6017362 | shares |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
13265000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
12265000 | usd |
CY2020 | us-gaap |
Depreciation
Depreciation
|
1207000 | usd |
CY2022Q4 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
1600000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
1444000 | usd |
CY2021Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
4000 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
2275000 | usd |
CY2020Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
460000000 | usd |
CY2020Q4 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0 | pure |
CY2020Q4 | fvrr |
Debt Instrument Convertible Initial Conversion Rate
DebtInstrumentConvertibleInitialConversionRate
|
4.6823 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
1 | |
CY2020Q4 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
213.57 | |
CY2020Q4 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2025-11-01 | |
CY2020Q4 | us-gaap |
Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
|
Prior t | |
CY2020Q4 | us-gaap |
Debt Instrument Redemption Period End Date
DebtInstrumentRedemptionPeriodEndDate
|
2023-11-05 | |
CY2020Q4 | us-gaap |
Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
|
1.30 | pure |
CY2020Q4 | us-gaap |
Debt Instrument Convertible Threshold Trading Days
DebtInstrumentConvertibleThresholdTradingDays
|
20 | days |
CY2020Q4 | us-gaap |
Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
|
30 | days |
CY2020Q4 | us-gaap |
Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
|
1 | pure |
CY2020Q4 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
9969000 | usd |
CY2020Q4 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
2842000 | usd |
CY2020Q4 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.051 | pure |
CY2022Q4 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.0056 | pure |
CY2022Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
460000000 | usd |
CY2021Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
460000000 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
0 | usd |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
85478000 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
7236000 | usd |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
2446000 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
452764000 | usd |
CY2021Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
372076000 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
|
0 | usd |
CY2021Q4 | us-gaap |
Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
|
99190000 | usd |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
560060 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
61.91 | |
CY2022 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
282479 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
12.99 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
89965 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
83.29 | |
CY2022 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | usd |
CY2021 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
19473000 | usd |
CY2020 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
3677000 | usd |
CY2022 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
2527000 | usd |
CY2021 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
556000 | usd |
CY2020 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
359000 | usd |
CY2022 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
2527000 | usd |
CY2021 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
20029000 | usd |
CY2020 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
4036000 | usd |
CY2022Q4 | us-gaap |
Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
12258000 | usd |
CY2022Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1559000 | usd |
CY2021Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
841000 | usd |
CY2022Q4 | fvrr |
Long Term Loan And Long Term Liabilities
LongTermLoanAndLongTermLiabilities
|
1559000 | usd |
CY2021Q4 | fvrr |
Long Term Loan And Long Term Liabilities
LongTermLoanAndLongTermLiabilities
|
13099000 | usd |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2908598 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
47.85 | |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y14D | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3096214 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
52.54 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y3M7D | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
2176521 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
32.85 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y25D | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
25.24 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
130.95 | |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
27.85 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
10873000 | usd |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
142419000 | usd |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
128463000 | usd |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
23346000 | usd |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
25536000 | usd |
CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
12620000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
71755000 | usd |
CY2021 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
55407000 | usd |
CY2020 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
15815000 | usd |
CY2022Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
144610000 | usd |
CY2022 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y6M18D | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
61779000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
36490000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
CY2022Q4 | fvrr |
Deferred Tax Assets Issuance Costs
DeferredTaxAssetsIssuanceCosts
|
0 | usd |
CY2021Q4 | fvrr |
Deferred Tax Assets Issuance Costs
DeferredTaxAssetsIssuanceCosts
|
630000 | usd |
CY2022Q4 | fvrr |
Total Deferred Tax Assets Liabilities Net Before Valuation Allowance
TotalDeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
|
61779000 | usd |
CY2021Q4 | fvrr |
Total Deferred Tax Assets Liabilities Net Before Valuation Allowance
TotalDeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
|
36490000 | usd |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.24 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.25 | pure |
CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.23 | pure |
CY2017Q1 | fvrr |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Preferred Enterprises Located In Development Area Percent
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePreferredEnterprisesLocatedInDevelopmentAreaPercent
|
0.075 | pure |
CY2017 | fvrr |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Preferred Enterprises Located In Development Area Percent
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePreferredEnterprisesLocatedInDevelopmentAreaPercent
|
0.09 | pure |
CY2018 | fvrr |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Preferred Enterprises Located In Other Than Development Area Percent
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePreferredEnterprisesLocatedInOtherThanDevelopmentAreaPercent
|
0.16 | pure |